Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find below the schedule of meeting with Analyst(s) / Institutional Investor(s) dated February 22, 2022. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. please find below the schedule of meeting with Analyst(s) / Institutional Investor(s) dated February 21, 2022. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find below the schedule of meeting with Analyst(s) / Institutional Investor(s) dated February 18, 2022. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Further to the Company's letters dated February 7, 2022, February 8, 2022 and February 11, 2022 regarding an earnings conference call with investor(s) and analyst(s) on Saturday, February 12, 2022 to discuss the financial performance of the Company for the quarter and nine months ended December 31, 2021,please find attached the transcript of the call. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find below the schedule of meetings with Analyst(s) / Institutional Investor(s) from February 15, 2022 to February 17, 2022. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed the schedule of analyst(s) / institutional investor(s) meeting held on Monday, February 14, 2022
Earnings Call for Q3FY22 of Star Health and Allied Insurance Company
Conference Call with Star Health and Allied Insurance Company Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the extract of Audited Financial Results for the quarter and nine months ended December 31, 2021 published in Financial Express (English Edition) and Dinamani (Tamil Edition). Star Health and Allied Insurance Company Ltd - 543412 - Submission Of Statement Of Deviation Or Variation -December 31, 2021.
In compliance with Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019 we hereby confirm that there is no deviation or variation in use of proceeds raised through initial public offer. Star Health and Allied Insurance Company Ltd - 543412 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to the Company's letter dated February 7, 2022 and February 8, 2022 giving intimation and the pre-registration link for the Conference Call, please find enclosed the Investor presentation on performance of the Company, to be made to the Investors and Analysts on Saturday, February 12, 2022 for the nine months and quarter ended as on December 31, 2021.